Title: Unmasking Staphylococcus aureus: Why Vaccines Fail and New Hope for Effective Protection
Article:
Staphylococcus aureus (S. aureus) is a formidable adversary, responsible for more than a million deaths worldwide annually. This bacteria wreaks havoc, causing skin infections, food poisoning, strep throat, sepsis, and toxic shock syndrome, which can lead to organ failure. Yet, our immune system struggles to combat it, and vaccines fall short despite promising preclinical results. New research from the University of California San Diego (UCSD) offers insights into this immune system dilemma and potential strategies to counter this resilient pathogen.
The Bacteria’s Defense Mechanism
S. aureus has developed a crafty way to manipulate our immune system. A recently published study in the Journal of Clinical Investigation reveals that this bacteria induces B-cells to produce an abundance of interleukin-10 (IL-10), a Protein that essentially dampens our immune response. B-cells typically produce antibodies to identify and destroy harmful invaders, but IL-10 disrupts this process.
IL-10 activates enzymes that attach a type of sugar called sialic acid to the Fc region of antibodies. This region binds to immune cells, and by altering it, S. aureus effectively disables the antibodies, rendering them unable to fight the bacteria. "The IL-10 causes an overproduction of sialic acid, leaving our immune system unable to mount an effective attack," explains lead researcher Chih-Ming Tsai from UCSD School of Medicine.
Why Vaccines Fail
Vaccines designed to protect against S. aureus often work perfectly in mice that have never encountered the bacteria before. However, in humans, who are usually exposed to S. aureus at a young age through the nose, these vaccines fall short. The issue lies in the ineffective ‘memory’ antibodies built up over time. When researchers mimicked human exposure in mice before vaccinating them, the vaccines failed. But when they blocked the IL-10 protein during vaccination, the vaccines’ efficacy was fully restored.
Unraveling the Role of T-Cells
A second study, published in Nature, focused on CD4+ T-cells, or ‘helper T-cells,’ which coordinate the immune response by activating other immune cells. Exposure to S. aureus also induces these cells to produce excessive IL-10, which suppresses the production of a crucial protein, interleukin-17A (IL-17A), typically needed to combat the infection. By blocking IL-10 or introducing a substance called CAF01 during vaccination, researchers successfully restored IL-17A production and made earlier ineffective vaccines against S. aureus highly effective.
New Hope for Vaccines
These findings offer new hope in the development of vaccines against deadly staph infections. By blocking IL-10 or bolstering the immune response with substances like CAF01, previously failed vaccines can be revived. Moreover, IL-10’s role seems to extend beyond S. aureus, playing a part in the failure of vaccines against malaria and Clostridioides difficile, a gut bacterium that can swiftly multiply and produce toxins when the balance of gut microbiota is disturbed, often due to antibiotic use.
Targeting these tiny messenger proteins, or cytokines, opens up promising new avenues. In the near future, we could potentially revitalize various ‘failed’ vaccines, saving countless lives from infectious diseases. The persistent battle against S. aureus continues, but with newfound understanding and innovative strategies, the tide may finally turn in our favor.
Image caption: Irshad Hajam and Chih-Ming Tsai at work in the Liu Lab. Photo: Kyle Dykes/UC San Diego Health Sciences
Sources:
- "Staphylococcus aureus renders antibodies ineffective through Fc 原 region sialylation." Journal of Clinical Investigation, 130.17 (2020).
- "IL-10 impairs T cell-mediated immunity to Staphylococcus aureus." Nature, (2020).
